Since this study was designed as a pilot trial with a short observation period (56 days), further studies are needed to clarify the long-term effect of a single or repeated oral FMT on cAD using a large population of dogs with mild to severe AD and appropriate controls
Adverse medication reactions
p = 0.04), indicating a significant reduction in FBS levels (Figure 15)
Rahbar MH, Samms-Vaughan M, Lee M, Zhang J, Hessabi M, Bressler J, Bach MA, Grove ML, Shakespeare-Pellington S, Beecher C, McLaughlin W, Loveland KA (2020) Interaction between a mixture of heavy metals (lead, mercury, arsenic, cadmium, manganese, aluminum) and GSTP1, GSTT1, and GSTM1 in relation to autism spectrum disorder
Siddhi Camila Lama is a bioengineer, clinical researcher, and science communicator specializing in regenerative medicine, hair restoration, and public health